CLYM

Climb Bio, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website -
Employees(FY) -
ISIN US28658R1068

Performance

-30.85%

-40.0%

-76.45%

-73.47%

-27.78%

YTD

-27.51%

Profile

Advanced Technical Analysis

Technical Analysis of CLYM 2024-12-20

The stock indicators reflect a bearish sentiment overall, with a Moving Average Score of 10 indicating strong downward momentum, an Oscillators Score of 43 suggesting a neutral stance, and a Technical Score of 26 reinforcing the bearish outlook. This combination signals caution for potential investors, as the prevailing trend appears to be negat...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of CLYM

Stock Rank

Recent News & Updates

2024-12-18 18:00
Climb Bio to be Added to the Nasdaq Biotechnology Index(Globenewswire)
2024-11-12 03:05
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights(Globenewswire)
2024-11-10 18:00
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board(Globenewswire)
2024-10-30 19:00
Climb Bio to Present at Upcoming Investor Conferences(Globenewswire)
2024-10-14 19:00
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event(Globenewswire)
2024-10-11 00:30
Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024(Globenewswire)
2024-10-03 19:00
Climb Bio to Present at William Blair's Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19(Globenewswire)
2024-10-02 22:00
Climb Bio to Host Virtual Investor Event on October 15, 2024(Globenewswire)
2024-10-02 07:04
Eliem Therapeutics Changes Name to Climb Bio(Yahoo Finance)
2024-10-01 21:00
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.(Globenewswire)
2024-09-10 19:00
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit(Globenewswire)
2024-08-25 19:00
Eliem Therapeutics Announces Additions to its Leadership Team(Globenewswire)
2024-08-13 18:05
Eliem Therapeutics Reports Second Quarter Financial Results(Globenewswire)
2024-07-23 12:11
Insider Sale at Eliem Therapeutics Inc: EVP, R&D AND CSO Valerie Morisset Sells Shares(Yahoo Finance)
2024-07-19 03:00
Insider Sale at Eliem Therapeutics Inc (ELYM): EVP, R&D AND CSO Valerie Morisset Sells ...(Yahoo Finance)
2024-07-17 13:01
EVP, R&D AND CSO Valerie Morisset Sells 50,000 Shares of Eliem Therapeutics Inc (ELYM)(Yahoo Finance)
2024-07-16 12:42
Insider Sale at Eliem Therapeutics Inc (ELYM): EVP, R&D AND CSO Valerie Morisset Sells ...(Yahoo Finance)
2024-07-11 13:46
Insider Sale at Eliem Therapeutics Inc: EVP, R&D AND CSO Valerie Morisset Sells 105,931 Shares(Yahoo Finance)
2024-06-27 19:00
Eliem Therapeutics Announces its Addition to the Russell 2000 and Russell 3000 Indexes(Globenewswire)
2024-06-27 04:01
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement(Globenewswire)
2024-05-15 01:53
ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q1 2024(Investorplace)
2024-04-11 02:42
Eliem Therapeutics Shifts From Neurology With New Found Focus On Autoimmune Diseases With Tenet Medicines Deal(Yahoo Finance)
2024-04-10 19:00
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement(Globenewswire)
2024-04-04 18:53
ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q4 2023(Investorplace)
2023-07-20 19:17
Eliem (ELYM) to Explore Strategic Options, Stock Rises 6%(Yahoo Finance)
2023-07-19 18:45
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives(Yahoo Finance)
2023-05-11 04:10
Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights(Yahoo Finance)
2023-04-21 00:00
We're Hopeful That Eliem Therapeutics (NASDAQ:ELYM) Will Use Its Cash Wisely(Yahoo Finance)
2023-04-20 22:39
Top 10 Stocks Activist Investors Are Targeting(Yahoo Finance)
2023-03-06 03:10
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights(Yahoo Finance)

Page 1 of 3

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.